| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oric Pharmaceuticals, Inc. | Director | Common Stock | 28,000 | $264,040 | $9.43 | 23 Jun 2025 | Direct |
| Oric Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 40,000 | 02 Jan 2026 | Direct | ||
| RayzeBio, Inc. | Director | Employee Stock Option (right to buy) | 0 | 26 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ORIC | Oric Pharmaceuticals, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Director | 06 Jan 2026, 16:49 |
| ORIC | Oric Pharmaceuticals, Inc. | 20 Jun 2025 | 2 | +$262,899 | 4 | Director | 23 Jun 2025, 20:05 |
| ORIC | Oric Pharmaceuticals, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Director | 06 Jan 2025, 16:47 |
| ORIC | Oric Pharmaceuticals, Inc. | 12 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:26 |
| /report/000141588924005545-you-angie-2024-02-26 | RayzeBio, Inc. | 26 Feb 2024 | 2 | $0 | 4 | Director | 27 Feb 2024, 17:10 |
| /report/000120919123049510-you-angie-2023-09-14 | RayzeBio, Inc. | 14 Sep 2023 | 0 | $0 | 3 | Director | 14 Sep 2023, 20:32 |
| ORIC | Oric Pharmaceuticals, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:58 |
| ORIC | Oric Pharmaceuticals, Inc. | 17 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 20:25 |
| ORIC | Oric Pharmaceuticals, Inc. | 09 Nov 2021 | 1 | $0 | 4 | Director | 10 Nov 2021, 16:53 |
| ORIC | Oric Pharmaceuticals, Inc. | 09 Nov 2021 | 0 | $0 | 3 | Director | 10 Nov 2021, 16:51 |